Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interchangeability of Quinvaxem in Healthy Infants
NCT01357720Phase 4Completed
- Sponsor
- Crucell
- Start
- May 2011
- Primary completion
- Sep 2011
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Quinvaxem in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Crucell. Started May 2011; status: completed.
02
Drugs
Quinvaxem
03
Conditions
diphtheriaTetanuspertussishepatitis B (HBV)Haemophilus influenzae type b infection (Hib)
Beyond the preview
Go deeper on NCT01357720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01357720.